Flublok influenza vaccine for the 2013-14 season now available

Nov 14 2013

Protein Sciences Corporation, the manufacturer of Flublok, the new, pure influenza vaccine containing no egg proteins, influenza virus, preservatives (e.g., thimerosal), antibiotics, gelatin or latex, announced today that doses for the 2013-14 season have been released by the FDA and are now available. Quantities of Flublok are limited and will be distributed on a first-come, first-served basis exclusively by FFF Enterprises.

Flublok, a cutting-edge class of influenza vaccine called RIV3 (recombinant hemagglutinin influenza vaccine, trivalent formulation), is made by making just the active ingredient needed for protection without growing influenza virus.  The vaccine contains 3 times the protective ingredient in traditional flu vaccines.  

The CDC recommends the use of Flublok for all adults 18-49 years old and specifically for those in that age range who have a known or suspected egg allergy, regardless of severity.

SOURCE Protein Sciences Corporation